{"certainAgreement":{"otherDetails":"The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"clinicaltrials@pharmamar.com","organization":"Pharma Mar S.A.","phone":"0034 91846 60 00","title":"Clinical Development, Department of PharmaMar´s Oncology., Business Unit."}}